Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density. [PDF]
Pradhan S +3 more
europepmc +1 more source
Evaluating the Comparative Effectiveness of Sodium-Glucose Transporter 2 Inhibitors (SGLT-2i) on Liver Enzymes in Patients With Nonalcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Khalil I, Hossain MI, Akter M.
europepmc +1 more source
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non-diabetic veterinary patients with cardiac and kidney diseases? [PDF]
Elliott J, Oyama MA.
europepmc +1 more source
Missed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis. [PDF]
Kim HA, Kim JY, Kim YH, Lee YT, Park PW.
europepmc +1 more source
Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
Risk of Dementia in Patients with Diabetes Using Sodium-Glucose Transporter 2 Inhibitors (SGLT2i): A Systematic Review, Meta-Analysis, and Meta-Regression. [PDF]
Gunawan PY, Gunawan PA, Hariyanto TI.
europepmc +1 more source
Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study. [PDF]
Chang HC +7 more
europepmc +1 more source
Fournier's gangrene and sodium-glucose co-transporter 2(SGLT2) inhibitors: Our experience
Ashwitha S Dass +2 more
doaj +1 more source
Renal Effects of Sodium-glucose-linked Transporter 2 Inhibitors
M Rajasekara Chakravarthi, Hari K Marri
openaire +1 more source

